Astrazeneca (AZN) Capital Expenditures (2009 - 2026)
Astrazeneca (AZN) reported Capital Expenditures of -$763 million for Q2 2026, compared with -$659 million a year earlier.
Powered by 
Analysis
Astrazeneca (AZN) Capital Expenditures (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Astrazeneca's Capital Expenditures came in at -$3.03 billion; for FY2025, it came in at -$2.81 billion.
- By year, Capital Expenditures came in at -$1.92 billion in FY2024, -$1.36 billion in FY2023, -$1.09 billion in FY2022 and -$1.09 billion in FY2021.
- Five-year quarterly Capital Expenditures spans a low of -$1.04 billion in Q4 2025 and a high of -$219 million in Q1 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$547 million (Q1 2026), -$1.04 billion (Q4 2025) and -$686 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | 237.00 Mn |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Vertex Pharmaceuticals | 141.76 Bn | 113.76 Bn | 2.84 Bn | 112.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Bn |
| Mar 31, 2026 | -547.00 Mn |
| Dec 31, 2025 | 4.58 Bn |
| Sep 30, 2025 | -2.86 Bn |
| Jun 30, 2025 | 1.52 Bn |
| Mar 31, 2025 | -429.00 Mn |
| Dec 31, 2024 | 3.14 Bn |
| Sep 30, 2024 | -2.02 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | -417.00 Mn |
| Jun 30, 2023 | 764.00 Mn |
| Mar 31, 2023 | -247.00 Mn |
| Jun 30, 2022 | 691.00 Mn |
| Mar 31, 2022 | -219.00 Mn |
| Dec 31, 2021 | 1.86 Bn |
| Sep 30, 2021 | -1.28 Bn |
| Jun 30, 2021 | 728.00 Mn |
| Mar 31, 2021 | -220.00 Mn |
| Dec 31, 2020 | 1.56 Bn |
| Sep 30, 2020 | -968.00 Mn |
API Access
Astrazeneca Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();